Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1470)	1/10/2006 12:35:51 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

EXAS Continued with the upmove after my comments on Dec.23 Today is up another 39%with volume now above 858Ks. bigcharts.marketwatch.com It announced today that improvements to its technology demonstrated sensitivity in excess of 80% for detecting colorectal Ca. Bernard

To: Jibacoa who wrote (1470)	9/20/2007 10:42:25 AM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

EXAS was up 29% earlier, apparently after some comments about its fecal test for colon Ca in an article in Belgium. Subject 51792 The stock needs to close above $4, but the R/R seems reasonable at present levels.<g> bigcharts.marketwatch.com It is now almost 2Yrs since Tin Beyers at the Motley Fool commented on EXAS having a gross margin of 95.4% and mentioned its DNA-based test for colorectal Ca.<g> But EXAS has been trimming its loss in the last few Qs in spite of its lower revenues & it has no significant LTD. The insiders reportedly hold around 10%. siliconinvestor.com Bernard